Research Article

Type B Progesterone Receptor Polymorphism Increases the Risk of Pelvic Organ Prolapse in Balinese Women

I Gede Mega Putra
Sanglah Hospital, Indonesia
I Wayan Megadhana
Sanglah Hospital, Indonesia
Putu Doster Mahayasa
Sanglah Hospital, Indonesia
Made Suyasa Jaya
Sanglah Hospital, Indonesia
I Gusti Ngurah Harry Wijaya Surya
Sanglah Hospital, Indonesia
Ngakan Ketut Darmawan
Sanglah Hospital, Indonesia
* Corresponding author
DOI icon 10.24018/ejmed.2022.4.4.1383

Read Counter
592

Downloads
416

Citations

Share

Article Sidebar

Submitted 2022-06-03
Published 2022-07-12

Read counter = 592 times

Table of Contents

Article Main Content

This study aims to determine the role of type B progesterone receptor gene polymorphisms as a risk factor for pelvic organ prolapse in Balinese women. This paired case-control study involves 29 patients with pelvic organ prolapse as the case group and 29 patients without pelvic organ prolapse as the control group. The study was conducted at Sanglah Hospital, Denpasar and the Integrated Biomedical Laboratory, Faculty of Medicine, Udayana University. Three milliliters of venous blood samples were taken from each patient and PCR examination was performed to determine the type b progesterone receptor gene polymorphisms. Risk assessment of the type b progesterone receptor gene polymorphism for pelvic organ prolapse was done by controlling for confounding variables, including age, parity, body mass index, occupation, menopausal status, and history of hysterectomy, through multiple logistic regression tests. The type b progesterone receptor gene polymorphism increased the risk of pelvic organ prolapse three times compared to non-prolapsed in Balinese women (OR 3.90, 95%CI 1.16-13.07, p = 0.023). After controlling for various confounding variables, type b progesterone receptor gene polymorphism still increased the risk of pelvic organ prolapse up to four times (AOR 4.54, 95%CI 1.16-17.68, p = 0.029). The type b progesterone receptor gene polymorphism significantly increases the risk of pelvic organ prolapse in Balinese women.

Keywords: Polymorphism, type B progesterone receptor, pelvic organ prolapse

References

  1. Dietz HP. Pelvic organ prolapse – a review. Australian Journal for General Practitioners. 2015; 44: 446-452.
     Google Scholar
  2. Milart P, Woźniakowska E, Czuczwar P, Woźniak S. Pelvic organ prolapse in women: how is it diagnosed and treated currently? Prz menopauzalny= Menopause Rev. 2015; 14(3): 155.
    DOI  |   Google Scholar
  3. Wilkins MF, Wu JM. Epidemiology of pelvic organ prolapse. Curr Obstet Gynecol Rep. 2016; 5(2): 119–23.
    DOI  |   Google Scholar
  4. Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Bai SW. Risk factors for pelvic organ prolapse. Int J Gynaecol Obstet. 2007; 98(3): 248-251.
    DOI  |   Google Scholar
  5. Razzak L. Pathophysiology of Pelvic Organ Prolapse. In: Pelvic Floor Disorders. IntechOpen. 2018.
    DOI  |   Google Scholar
  6. Ward RM, Velez Edwards DR, Edwards T, Giri A, Jerome RN, Wu JM. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol. 2014; 211(4): 326-335.
    DOI  |   Google Scholar
  7. Lim VF, Khoo JK, Wong V, Moore KH. Recent studies of genetic dysfunction in pelvic organ prolapse: the role of collagen defects. Aust New Zeal J Obstet Gynaecol. 2014; 54(3): 198–205.
    DOI  |   Google Scholar
  8. Krissi H, Halperin R, Koren R, Peled Y. The presence and location of estrogen and progesterone receptors in the human pelvic cardinal ligaments. Pelviperineology. 2010; 29(1): 17–9.
     Google Scholar
  9. Bai SW, Yoon JM, Shin JS, Kim SK, Park KH. Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J. 2005; 16(6): 492–6.
    DOI  |   Google Scholar
  10. Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics. 2015; 8(1): 1–7.
    DOI  |   Google Scholar
  11. Jacobsen BM, Horwitz KB. Progesterone receptors, their isoforms and progesterone regulated transcription. Mol Cell Endocrinol. 2012; 357(1–2): 18–29.
    DOI  |   Google Scholar
  12. Chen H-Y, Chung Y-W, Lin W-Y, Chen W-C, Tsai F-J, Tsai C-H. Progesterone receptor polymorphism is associated with pelvic organ prolapse risk. Acta Obstet Gynecol Scand. 2009; 88(7): 835–8.
    DOI  |   Google Scholar
  13. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014; 123(1): 141.
    DOI  |   Google Scholar
  14. Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2019; 46: 5–14.
    DOI  |   Google Scholar
  15. Horst W, Do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017; 28(8): 1165–70.
    DOI  |   Google Scholar
  16. Fatima Q, Razzaqe H, Kashif M, Aslam F. Association of parity and pelvic organ prolapse. JRMC. 2016.
     Google Scholar
  17. Vergeldt TFM, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015; 26(11): 1559–73.
    DOI  |   Google Scholar
  18. Patel DA, Xu X, Thomason AD, Ransom SB, Ivy JS, DeLancey JO. Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery. Am J Obstet Gynecol. 2006; 195(1): 23-28.
    DOI  |   Google Scholar
  19. Forner LB, Beckman EM, Smith MD. Symptoms of pelvic organ prolapse in women who lift heavy weights for exercise: a cross-sectional survey. Int Urogynecol J. 2020; 31(8): 1551–8.
    DOI  |   Google Scholar
  20. Koyuncu A, Kadota JL, Mnyippembe A, Njau PF, Sijali TR, McCoy SI, et al. Heavy Load Carrying and Symptoms of Pelvic Organ Prolapse among Women in Tanzania and Nepal: An Exploratory Study. Int J Environ Res Public Health. 2021; 18(3): 1279.
    DOI  |   Google Scholar
  21. Young N, Atan IK, Rojas RG, Dietz HP. Obesity: how much does it matter for female pelvic organ prolapse? Int Urogynecol J. 2018; 29(8): 1129–34.
    DOI  |   Google Scholar
  22. Orejuela FJ, Shek KL, Dietz HP. The time factor in the assessment of prolapse and levator ballooning. Int Urogynecol J. 2012; 23(2): 175–8.
    DOI  |   Google Scholar
  23. Ramalingam K, Monga A. Obesity and pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2015; 29(4): 541–7.
    DOI  |   Google Scholar
  24. de Sam Lazaro S, Nardos R, Caughey AB. Obesity and pelvic floor dysfunction: battling the bulge. Obstet Gynecol Surv. 2016; 71(2): 114–25.
    DOI  |   Google Scholar
  25. Sze EHM, Hobbs G. A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre-and post-menopausal women. Eur J Obstet Gynecol Reprod Biol. 2012; 160(2): 232–5.
    DOI  |   Google Scholar
  26. Forsgren C, Lundholm C, Johansson ALV, Cnattingius S, Zetterström J, Altman D. Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery. Int Urogynecol J. 2012; 23(1): 43–8.
    DOI  |   Google Scholar
  27. Lykke R, Løwenstein E, Blaakær J, Gimbel H. Hysterectomy technique and risk of pelvic organ prolapse repair: a Danish nationwide cohort study. Arch Gynecol Obstet. 2017; 296(3): 527–31.
    DOI  |   Google Scholar
  28. Dallas K, Elliott CS, Syan R, Sohlberg E, Enemchukwu E, Rogo-Gupta L. Association between concomitant hysterectomy and repeat surgery for pelvic organ prolapse repair in a cohort of nearly 100,000 women. Obstet Gynecol. 2018; 132(6): 1328–36.
    DOI  |   Google Scholar
  29. Zong W, Meyn LA, Moalli PA. The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod. 2009; 80(2): 367–74.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 > >>